CDK2 Inhibition and Eradication of Aneuploid Cancers: Promise Meets Resistance
{{output}}
Aneuploidy is a cancer hallmark that causes resistance to anticancer drugs and promotes aggressive tumors. Thus, aneuploidy is a consequential feature of human malignancy. This review addresses how cyclin dependent kinase 2 (CDK2) inhibition targets a broad ar... ...
